Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Dilly Stephen George
Relationship:   CEO and President, Dir...
City:   Alameda
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   912,611    

Indirect Shares

  131,700      
Direct Value   $12,909,247    

Indirect Value

  $4,542,333      
Total Shares   1,044,311      
Total Value   $17,451,580      


Aimmune Therapeutics, Inc.
 $10,874,973 Sangamo Biosciences Inc
 $7,860 Codexis Inc
 $2,026,414 Aimmune Therapeutics, Inc.
 $10,874,973 Sangamo Biosciences Inc
 $7,860 Codexis Inc
 $2,026,414
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    2    

     Stock price went up :

    2   
    0    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   2.0   
   -2.0   
     Percentage Gain/Loss :
   85.3%
 -115.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aimmune Therapeutics, Inc. AIMT President and CEO, Dir... 2018-06-11 315,308 2018-06-11 131,700    Premium*  
            Sangamo Biosciences Inc SGMO Director 2020-05-18 15,000 2018-06-11 0    Premium*  
            Codexis Inc CDXS 2024-01-01 582,303 2020-06-16 0    Premium*  
            Sierra Oncology Inc SRRA CEO and President, Dir... 2022-07-01 0 2021-05-19 0    Premium*  
* Premium Members only  

Records found :    56         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AIMT Aimmune Therapeutics, Inc... President and CEO   •       •      –    2018-06-07 4 OE $3.02 $98,514 D/D 32,598 347,906 0 -
AIMT Aimmune Therapeutics, Inc... President and CEO   •       •      –    2018-06-08 4 AS $30.70 $1,292,511 D/D (42,106) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... President and CEO   •       •      –    2018-06-08 4 OE $3.02 $127,249 D/D 42,106 357,414 0 -
AIMT Aimmune Therapeutics, Inc... President and CEO   •       •      –    2018-06-11 4 AS $30.83 $908,301 D/D (29,457) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... President and CEO   •       •      –    2018-06-11 4 OE $3.02 $89,022 D/D 29,457 344,765 0 -
AIMT Aimmune Therapeutics, Inc... President and CEOOfficer   •       •      –    2015-08-05 3 IO $0.00 $0 D/D 0 765,308 -
AIMT Aimmune Therapeutics, Inc... President and CEOOfficer   •       •      –    2015-08-05 3 IO $0.00 $0 I/I 0 131,700 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-07-25 4 GA $0.00 $0 D/D 14,447 779,755 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-07-25 4 GA $0.00 $0 I/I 14,447 14,447 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-07-25 4 GD $0.00 $0 I/I 28,894 51,403 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-08-24 4 GD $0.00 $0 D/D 14,447 765,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-08-24 4 GD $0.00 $0 I/I 14,447 0 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-08-24 4 GA $0.00 $0 I/I 28,894 14,447 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-11-10 4 AS $25.00 $32,600 D/D (1,304) 764,004 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2016-11-11 4 AS $25.00 $1,217,990 D/D (48,696) 715,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2017-05-10 4 AS $20.15 $12,090 D/D (600) 714,708 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2017-10-12 4 GA $0.00 $0 I/I 4,876 25,532 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2017-10-12 4 GD $0.00 $0 I/I 4,876 12,009 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2017-10-23 4 AS $33.23 $3,354,538 D/D (100,000) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-01 4 OE $3.02 $184,943 D/D 61,197 376,505 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-01 4 AS $32.59 $1,995,993 D/D (61,197) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-04 4 AS $31.84 $2,083,356 D/D (65,352) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-04 4 OE $3.02 $197,500 D/D 65,352 380,660 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-05 4 AS $31.83 $1,235,835 D/D (38,825) 315,308 0 -
AIMT Aimmune Therapeutics, Inc... See Remarks   •       •      –    2018-06-05 4 OE $3.02 $117,333 D/D 38,825 354,133 0 -

  56  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed